FIELD: medicine.
SUBSTANCE: invention refers to medicine and pharmacology and represents a method for preparing the composition of high-molecular heparin with amino acids and 3-d metals. Method involves mixing of aqueous solutions of heparin, amino acid and salt of 3-d metal. Note here that mixing is performed in molar ratio 1:1:1 at temperature 37°C, certain pH, ionic force 0.15 M NaCl, then composition is precipitated with the help of polar aprotic solvent - acetone in the ratio composition/acetone: 1/1.25, held in thermostat at temperature 0°C for 180 minutes, decanted, centrifuged at 8,000-1,000 rpm and the precipitate is dried in a drying chamber at t = 60°C during 60 minutes.
EFFECT: compositions produced by this method contain the vital amino acids and microelements decomposable in bloodstream due to the difference between medium pH (7.3) and pH stability of these compositions with the release of heparin, amino acids and microelements thus being a compensatory part in heparin therapy.
1 cl, 2 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
ANTITHROMBOTIC COMPLEX BASED ON HEPARIN, METHOD OF ITS PRODUCTION AND USE | 2015 |
|
RU2600817C2 |
PHARMACEUTICAL PREPARATION FOR PREVENTION AND TREATMENT OF PROGRESSIVE MYOPIA | 2013 |
|
RU2635185C2 |
EMULSION OF PERFLUORO-GANIC COMPOUNDS WITH INCREASED OXYGEN CAPACITY | 2022 |
|
RU2803466C2 |
COMPOSITIONS FOR ENHANCING ANTIBACTERIAL ACTIVITY OF MYELOPEROXIDASE AND METHODS OF THEIR APPLICATION | 2009 |
|
RU2529799C2 |
PEPTIDILE HETEROCYCLES USED TO TREAT THROMBIN- ASSOCIATED DISEASES | 1996 |
|
RU2181125C2 |
PEPTIDYLARGINALS AND METHODS FOR TREATMENT OF DISSEMINATED INTRAVASCULAR COAGULATION SYNDROME | 2002 |
|
RU2312856C2 |
FEED ADDITIVE BASED ON ZINC ETHYLENEDIAMINETETRAACETATE AND COMPLEX OF AMINO ACIDS FOR BIRDS AND FARM ANIMALS AND METHOD FOR ITS PRODUCTION | 2023 |
|
RU2823608C1 |
NOVEL ANALOGUES OF GLUCAGON-LIKE PEPTIDE, COMPOSITION AND METHOD OF USE | 2010 |
|
RU2557301C2 |
METHOD OF CONTROLLING MODIFICATION REACTION OF POLYPEPTIDE | 2009 |
|
RU2532850C2 |
MEDICINE FOR TREATMENT OF KERATICONUS AND OTHER DEGENERATIVE DISEASES OF CORNEA AND PHARMACEUTICAL AGENTS BASED THEREON | 2013 |
|
RU2683651C2 |
Authors
Dates
2016-07-27—Published
2015-06-30—Filed